The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ego Seeman

Department of Endocrinology and Medicine

Austin Health

University of Melbourne

Melbourne

Australia

[email]@unimelb.edu.au

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Endocrinology and Medicine, Austin Health, University of Melbourne, Melbourne, Australia. 2002 - 2010
  • Austin Health, University of Melbourne, Melbourne, Australia. 2004 - 2010
  • Austin Health, Centure Building, Repatriation Campus, Heidelberg, Australia. 2006 - 2010

References

  1. Bone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly. Seeman, E. J. Bone Miner. Res. (2010) [Pubmed]
  2. Rebuilding Humpty Dumpty with a serotonin inhibitor. Seeman, E. Nat. Med. (2010) [Pubmed]
  3. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. Seeman, E., Boonen, S., Borgström, F., Vellas, B., Aquino, J.P., Semler, J., Benhamou, C.L., Kaufman, J.M., Reginster, J.Y. Bone (2010) [Pubmed]
  4. Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. Seeman, E., Delmas, P.D., Hanley, D.A., Sellmeyer, D., Cheung, A.M., Shane, E., Kearns, A., Thomas, T., Boyd, S.K., Boutroy, S., Bogado, C., Majumdar, S., Fan, M., Libanati, C., Zanchetta, J. J. Bone Miner. Res. (2010) [Pubmed]
  5. Evidence that calcium supplements reduce fracture risk is lacking. Seeman, E. Clin. J. Am. Soc. Nephrol (2010) [Pubmed]
  6. Festschrift to honor Professor Pierre D. Delmas. Seeman, E., Lindsay, R., Kanis, J.A. Osteoporos. Int (2009) [Pubmed]
  7. To stop or not to stop, that is the question. Seeman, E. Osteoporos. Int (2009) [Pubmed]
  8. Bone modeling and remodeling. Seeman, E. Crit. Rev. Eukaryot. Gene Expr. (2009) [Pubmed]
  9. Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. Seeman, E., Devogelaer, J.P., Lorenc, R., Spector, T., Brixen, K., Balogh, A., Stucki, G., Reginster, J.Y. J. Bone Miner. Res. (2008) [Pubmed]
  10. Bone quality: the material and structural basis of bone strength. Seeman, E. J. Bone Miner. Metab. (2008) [Pubmed]
  11. Structural basis of growth-related gain and age-related loss of bone strength. Seeman, E. Rheumatology. (Oxford) (2008) [Pubmed]
  12. The periosteum--a surface for all seasons. Seeman, E. Osteoporos. Int (2007) [Pubmed]
  13. Non-compliance: the Achilles' heel of anti-fracture efficacy. Seeman, E., Compston, J., Adachi, J., Brandi, M.L., Cooper, C., Dawson-Hughes, B., Jönsson, B., Pols, H., Cramer, J.A. Osteoporos. Int (2007) [Pubmed]
  14. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?. Seeman, E. Bone (2007) [Pubmed]
  15. Anti-vertebral fracture efficacy of raloxifene: a meta-analysis. Seeman, E., Crans, G.G., Diez-Perez, A., Pinette, K.V., Delmas, P.D. Osteoporos. Int (2006) [Pubmed]
  16. Hot stuff--can't get enough. Seeman, E. Osteoporos. Int (2006) [Pubmed]
  17. Bone quality--the material and structural basis of bone strength and fragility. Seeman, E., Delmas, P.D. N. Engl. J. Med. (2006) [Pubmed]
  18. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. Seeman, E., Vellas, B., Benhamou, C., Aquino, J.P., Semler, J., Kaufman, J.M., Hoszowski, K., Varela, A.R., Fiore, C., Brixen, K., Reginster, J.Y., Boonen, S. J. Bone Miner. Res. (2006) [Pubmed]
  19. Bone fragility in men--where are we?. Seeman, E., Bianchi, G., Khosla, S., Kanis, J.A., Orwoll, E. Osteoporos. Int (2006) [Pubmed]
  20. Preventing fractures--how good are we really?. Seeman, E. Nature Clinical Practice. Endocrinology & Metabolism (2006) [Pubmed]
  21. Diet and exercise during growth have site-specific skeletal effects: a co-twin control study. Iuliano-Burns, S., Stone, J., Hopper, J.L., Seeman, E. Osteoporos. Int (2005) [Pubmed]
  22. Loading and bone fragility. Seeman, E. J. Bone Miner. Metab. (2005) [Pubmed]
  23. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Seeman, E., Eisman, J.A. Med. J. Aust. (2004) [Pubmed]
  24. The growth and age-related origins of bone fragility in men. Seeman, E. Calcif. Tissue Int. (2004) [Pubmed]
  25. Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Seeman, E. Curr. Osteoporos. Rep (2004) [Pubmed]
  26. The structural and biomechanical basis of the gain and loss of bone strength in women and men. Seeman, E. Endocrinol. Metab. Clin. North Am. (2003) [Pubmed]
  27. Pathogenesis of bone fragility in women and men. Seeman, E. Lancet (2002) [Pubmed]
 
WikiGenes - Universities